United States · FDA National Drug Code directory

Virex

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
83027-0050_b4e8028f-66d0-4765-8dc7-1d7a1285fd74
Product NDC
83027-0050
Form
SPRAY
Composition / generic term
Asclepias Tuberosa, Echinacea Purpurea, Trifolium Pratense, Natrum Muriaticum, Phytolacca Decandra, Euphrasia Officinalis, Lac Vaccinum (NSPC), Thuja Occidentalis, Calcarea Arsenicica, Camphora, Influenzinum, Cytomegalovirus Nosode, Morbillinum, Variolinum, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B5 Nosode, Coxsackie A5 Nosode, Adenoviren Nosode, Epstein Barr Virus Nosode, Coxsackie B4 Nosode
Labeler
Nutritional Specialties, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20230413 / 20290105

Source-listed ingredients

  • ASCLEPIAS TUBEROSA ROOT — 3 [hp_X]/mL
  • ECHINACEA PURPUREA WHOLE — 3 [hp_X]/mL
  • TRIFOLIUM PRATENSE FLOWER — 3 [hp_X]/mL
  • SODIUM CHLORIDE — 4 [hp_X]/mL
  • PHYTOLACCA AMERICANA ROOT — 4 [hp_X]/mL
  • EUPHRASIA STRICTA — 6 [hp_X]/mL
  • COW MILK — 6 [hp_X]/mL
  • THUJA OCCIDENTALIS LEAFY TWIG — 6 [hp_X]/mL
  • CALCIUM ARSENATE — 12 [hp_X]/mL
  • CAMPHOR (NATURAL) — 12 [hp_X]/mL
  • INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
  • INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
  • HUMAN HERPESVIRUS 5 — 15 [hp_X]/mL
  • MEASLES VIRUS — 16 [hp_X]/mL
  • VARIOLA VIRUS — 16 [hp_X]/mL
  • HUMAN COXSACKIEVIRUS A2 — 9 [hp_C]/mL
  • HUMAN COXSACKIEVIRUS A — 9 [hp_C]/mL
  • HUMAN COXSACKIEVIRUS A7 — 9 [hp_C]/mL
  • HUMAN COXSACKIEVIRUS B1 — 9 [hp_C]/mL
  • HUMAN COXSACKIEVIRUS B3 — 9 [hp_C]/mL
  • HUMAN COXSACKIEVIRUS B5 — 9 [hp_C]/mL
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN — 15 [hp_C]/mL
  • HUMAN HERPESVIRUS 4 — 15 [hp_C]/mL
  • HUMAN COXSACKIEVIRUS B — 18 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 mL in 1 BOTTLE, SPRAY (83027-0050-1) · 83027-0050-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →